Programme (pdf)
8:30 – 8:35: Opening words: Prof. Teemu Murtola
Session 1 Chair: Prof. Teemu Murtola
8.35 – 9.20 KEYNOTE TALK: Dr. Vidhya Ravi
Tumor’s Ecosystem: Friend or Foe?
Department of Neurosurgery, Medical Centre, University of Freiburg,
Germany
9.20 – 9.32 Presentation selected based on submitted abstracts (10 + 2 min)
Erdogan Pekcan Erkan: Sustained epithelial interferon signaling modulates incomplete pathological response in colorectal cancer
9:32 – 9.45 Pitch talks (a 2 min)
- Luca Manninoa: Epitope Generation Gateway (EGG): A Context-Aware Pipeline for Neoantigen Prioritization and Cancer Immunotherapy
- Sasa Rauhalinna: Modular Plug and Play Recombinant 3D hydrogel system for studying cancer invasion
- Zhesi Zhang: MiREA: a network-based tool for global and cancer-specific miRNA- oriented enrichment analysis
- Peppi Kauppinen: Utilizing Cyclic Immunofluorescence to Detect Spatial Differentiation in Prostate Cancer -Atorvastatin versus placebo treated patients
- Göktuğ Karabiyik: Exploring the differential invasion patterns of glioblastoma and gliosarcoma cells on 3D hydrogel matrix.
- Laura Huhtala: DNA methylation based regulation and neuro-developmental trajectories of central nervous system tumors
9.45 –10.30 Poster session and Coffee, tea and snacks (45 min)
10.30 – 10.50 Prof. Anssi Auvinen: ProScreen randomised prostate
screening trial
SOC, Tampere University
10.50 – 11.15 Presentations selected based on submitted abstracts (a 10 + 2 min)
1) Aliisa M. Tiihonen: Hypoxia shapes Tumor Immune
microenvironment Through Cell-Type Dependent Responses in Diffuse
Astrocytomas
2) Konsta Kukkonen: Androgen receptor activation leads to divergent
chromatin regulation in nonmalignant and malignant prostate
epithelial cells
11.15 – 12.05 Lunch break (50 min) + Posters
Session 2 Chair: Director, Chief Physician Annika Auranen
12.05 – 12.50: KEYNOTE TALK: Prof. Ferdinando Chiaradonna:
Rethinking the Warburg effect in the light of Hexosamine Biosynthesis
Pathway
University of Milano-Bicocca, Dept of Biotechnology and Biosciences,
Tumor Biochemistry lab
12.50 – 13.10: Ass. Prof. Heidi Haikala: Studying lung cancer drug resistance using
fully human models
MET, Tampere University and University of Helsinki
13.10 – 13.50: Presentations selected based on submitted abstracts
(a 10 + 2 min)
- Argyro Bizaki-Vallaskangas: Novel genetic risk variants associated with oral tongue squamous cell carcinoma
- Lotta Isosaari: Exploring multicellular dynamics in glioblastoma: a 3D open-top chip model with integrated neurovascular networks for drug testing
- Ismaïl Hermelo: Unsupervised clustering reveals noncanonical myeloid cell subsets in the brain tumor microenvironment
13.50 – 14.10 Coffee break (20 min.)
Session 3 Chair: Prof. Toni Seppälä
14.10 – 14.55: KEYNOTE TALK: Prof. Lauri Aaltonen:
Uterine leiomyoma as a model for neoplasia
Faculty of Medicine, Department of Medical and Clinical Genetics,
University of Helsinki
14.55 – 15.15 Adj.Prof. Kirsi Rautajoki: Regulatory landscape of diffuse
astrocytomas
MET, Tampere University
15.15 – 15.55 Presentations selected based on submitted abstracts ( a 10+2 min)
1) Liang Zhang: A biologically informed AI framework for precise
stratification of cancer patients using their genomic features
2) Anja Hartewig: Integrative multi-modal analysis reveals the contribution
of noncoding RNAs to post-treatment progression of IDH-mutant
astrocytomas
3) Rafeul Hasan: Elucidating the Genetic Basis of Side Effects in users of
Androgen Signaling Inhibitors – A Focused Analysis of 5-alpha reductase
15.55 – 16.00 Closing words: Director Annika Auranen
Organisers: Tays Cancer Centre in collaboration with the Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Pirha